Replies to post #5480 on Lexington Biosciences Inc. (LXGTF)

[Door2Door]

OK Google it and got this " EndoPAT is an Innovative, safe and non-invasive diagnostic device for Functional Vascular Health Assessment for both large and small arteries. It is the only FDA cleared non-invasive test to evaluate the level of Endothelial Function." So basically the only direct FDA cleared competitor to LXGTF.